Purdue Pharma L.P.

Track this case

Case overview

Case Number:

7:19-bk-23649

Court:

New York Southern

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

October 25, 2021
Purdue Opposes Requests To Delay Ch. 11 Plan For Appeals

Purdue Pharma LP is arguing that delaying the consummation of its Chapter 11 plan to allow appeals to be resolved first would needlessly delay the distribution of billions of dollars for opioid abatement efforts while there was no danger of prejudice to the appellants.
October 20, 2021
Purdue Asks To Pay Ch. 11 Costs Of Government Committees

Bankrupt drugmaker Purdue Pharma LP asked for permission from a New York judge late Tuesday to pay $12.4 million in fees and expenses incurred by committees of nonconsenting state and local governments during a Chapter 11 plan mediation process.
October 14, 2021
Purdue Ch. 11 Plan Challenges Won't Hit 2nd Circ. Right Away

A New York bankruptcy judge on Thursday denied a motion from parties appealing the confirmation of Purdue Pharma's Chapter 11 plan to bypass the normal appellate channels and bring their arguments directly to the Second Circuit.
October 12, 2021
Purdue Ch. 11 Appeals To Be Heard Before Plan Effective Date

A Manhattan federal judge said Tuesday that she would hear oral arguments in the appeals of Purdue Pharma's Chapter 11 plan on Nov. 30 after adopting a briefing schedule proposed by the debtors and saying that she is committed to an expedited appeal process.
October 08, 2021
Canadian Creditors Seek Direct Appeal Of Purdue Ch. 11 Plan

A group of Canadian creditors told a New York bankruptcy judge that they support consolidating the appeals for Purdue Pharma's Chapter 11 plan and that those appeals should be allowed to move directly to the Second Circuit.
September 24, 2021
California AG Announces Appeal Of Purdue Ch. 11 Plan

California Attorney General Rob Bonta on Friday became the latest attorney general to announce an appeal of the approval of Purdue Pharma's Chapter 11 plan, saying the OxyContin maker's former owners in the Sackler family must be held accountable for their part in the opioid crisis.
September 22, 2021
US Trustee Challenges Constitutionality Of Purdue Releases

The nondebtor, third-party releases included in Purdue Pharma's Chapter 11 plan are unconstitutional, the U.S. Trustee's Office has argued, asking a New York bankruptcy judge to wait until a higher court rules on the federal watchdog's challenge to the releases.
September 16, 2021
US Trustee To Appeal Sackler Releases In Purdue Ch. 11

The U.S. Trustee's Office has told a New York bankruptcy judge it will appeal his order approving Purdue Pharma's Chapter 11 plan, saying the plan's liability releases for Purdue's Sackler family now-former owners go beyond the law and undermine confidence in the system.
September 13, 2021
Purdue Pharma Gets OK For $7.1M In Exec Incentives

A New York bankruptcy judge gave Purdue Pharma permission Monday to make incentive payments of up to $7.1 million to its top executives, rejecting arguments that the executives had not done enough to clean up the company's corporate culture.
September 01, 2021
Purdue Pharma Ch. 11 Plan Gets OK With Sackler Releases

A New York bankruptcy judge on Wednesday approved OxyContin maker Purdue Pharma's Chapter 11 plan, including contentious opioid liability releases for the company's now-former Sackler family owners.

← Previous
…
4
5
6
7
8
9
10
11
12
…
Next →